Biotricity, Inc. (OTCMKTS:BTCY) Short Interest Down 21.7% in September

Biotricity, Inc. (OTCMKTS:BTCY – Get Free Report) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 227,800 shares, a decline of 21.7% from the August 31st total of 291,100 shares. Based on an average daily volume of 40,700 shares, the days-to-cover ratio is [...]

featured-image

Biotricity, Inc. ( OTCMKTS:BTCY – Get Free Report ) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 227,800 shares, a decline of 21.

7% from the August 31st total of 291,100 shares. Based on an average daily volume of 40,700 shares, the days-to-cover ratio is presently 5.6 days.



Biotricity Stock Down 9.8 % OTCMKTS:BTCY traded down $0.03 during trading hours on Friday, reaching $0.

25. 66,387 shares of the stock were exchanged, compared to its average volume of 75,328. Biotricity has a twelve month low of $0.

24 and a twelve month high of $2.22. The business has a 50-day moving average of $0.

46 and a two-hundred day moving average of $0.90. The company has a market capitalization of $5.

41 million, a price-to-earnings ratio of -0.19 and a beta of 1.35.

Biotricity ( OTCMKTS:BTCY – Get Free Report ) last posted its earnings results on Monday, August 19th. The company reported ($0.49) earnings per share (EPS) for the quarter.

The company had revenue of $3.20 million during the quarter. On average, research analysts forecast that Biotricity will post -1.

43 EPS for the current fiscal year. Biotricity Company Profile Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.

Featured Stories Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter ..